Sort
23,748 grants matching “melanoma”
Macrophage-based ovarian cancer immunotherapy
$424,055Fiona E Yull · Vanderbilt University · R01 · FY2021 · CA
Pten/AKT and Siah in Regulation of Hypoxia
$423,991Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2013 · CA
Tissue-Based Cytokine Immunotherapy for Skin Cancer
$423,965Mary A. Lokuta · Stratatech Corporation · R44 · FY2010 · CA
Endothelial Transdifferentiation of Invasive Tumor Cells
$423,875Children'S Memorial Hospital (Chicago) · R37 · FY2005 · CA
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes
$423,859Marianne Berwick · University Of New Mexico Health Scis Ctr · P01 · FY2017 · CA
Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
$423,829Ralph R Weichselbaum · University Of Chicago · R01 · FY2024 · CA
HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition
$423,754Ravi K Amaravadi · University Of Pennsylvania · R01 · FY2013 · CA
Contribution of the cutaneous APC network to melanoma progression and therapy.
$423,750Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
Contribution of the cutaneous APC network to melanoma progression and therapy.
$423,750Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · CA
Validation of circulating tumor DNA assays for detection of metastatic melanoma
$423,750David Polsky · New York University School Of Medicine · UH3 · FY2018 · CA
Contribution of the cutaneous APC network to melanoma progression and therapy.
$423,750Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · CA
Contribution of the cutaneous APC network to melanoma progression and therapy.
$423,750Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA
Clinical production of viral vectors for cancer gene therapy
$423,627Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters
$423,523Avner Schlessinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
A role of balanced sex hormone in DNA repair in human melanocytes
$423,500Feng Liu-Smith · University Of Tennessee Health Sci Ctr · R21 · FY2023 · ES
ELUCIDATION & MODULATION OF NATURAL KILLER CELL SIGNALING: APPLICATION IN CANCER
$423,497Michael A Caligiuri · Ohio State University · P01 · FY2010 · CA
Dissecting the immunological mechanisms associated with prostate cancer progression in African-American men and exploring epigenetics-based immune modulation for therapy
$423,486Dennis O Adeegbe · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2021 · CA
Preventing Melanoma Metastasis by Targeting Lipid Vulnerabilities in Lymph
$423,468Jessalyn Ubellacker · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · CA
[18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors
$423,444Shivaani Kummar · Stanford University · R01 · FY2020 · CA
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
$423,426Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2024 · CA
Deciphering the tumor suppressive functions of macroH2A
$423,368Emily Bernstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Molecular Mechanisms of Telomere Length Homeostasis
$423,342Feng Qiao · University Of California-Irvine · R01 · FY2017 · GM
Isoprenylcysteine Carboxyl Methyltransferase (ICMT) as a Target in NRAS Driven Melanoma - Resubmission - 1
$423,242Mark Reid Philips · New York University School Of Medicine · R01 · FY2019 · CA
Isoprenylcysteine Carboxyl Methyltransferase (ICMT) as a Target in NRAS Driven Melanoma - Resubmission - 1
$423,242Mark Reid Philips · New York University School Of Medicine · R01 · FY2020 · CA
The Development of the Domestic Cat as an Animal Model for Genetic Analysis
$423,227Stephen J O'Brien · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA